ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Approximately 5–10% of CML patients lack the Philadelphia chromosome but exhibit detectable BCR–ABL1 oncogenes, with 25–50% displaying BCR–ABL1 gene rearrangement outside the Philadelphia chromosome [5].